MK175 is an IL-1beta inhibitor. MK175 reduces LPS (HY-D1056)-induced IL-1beta release in human aortic smooth muscle cells. MK175 is applicable to the research of cardiovascular inflammatory diseases such as atherosclerosis[1].
Molecular Weight:
370.45
Formula:
C13H18N6O3S2
Target:
Interleukin Related
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
